The UK NSC recommendation on Biliary atresia screening in newborns

Recommendation Systematic population screening programme not recommended
Last review completed December 2017
Next review due in 2020/21
Key downloads

Find general information about population health screening.

More about Biliary atresia

Biliary atresia affects about 1 in 16,000 babies at birth. In this condition, bile ducts are either blocked or absent. The cause of the condition is not clear and may vary. One of the most common early symptoms is jaundice (a yellow appearance of the skin or whites of the eyes) and pale stools.

If untreated the condition can lead to liver failure and death. The most common treatments for Biliary Atresia is the Kasai procedure (surgery that allows bile to drain directly into the bowel).


British Association for Study of the Liver
British Association of Perinatal Medicine
British Liver Nurses' Forum
The British Liver Trust
Children's Liver Disease Foundation
Faculty of Public Health
Royal College of General Practitioners
Royal College of Midwives
Royal College of Paediatrics and Child Health
Royal College of Physicians
Royal College of Physicians and Surgeons of Glasgow
Royal College of Physicians of Edinburgh

The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.

Related documents

icon Review of Biliary Atresia against UK NSC criteria - July 2012 (PDF document, 446KB, 27/07/12)
icon Review of Biliary Atresia against UK NSC criteria - July 2012 (PDF document, 446KB, 28/06/17)
icon Summary of Policy Recommendations and Consultation Responses for Biliary Atresia 20 March 2013 (PDF document, 375KB, 26/07/13)

More options

Go to top